Catamaran Bio

Allogene Therapeutics

The company develops off-the-shelf allogeneic CAR T-cell therapies for patients with blood cancers, solid tumours and autoimmune diseases.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.

Zelluna

This company develops T cell receptor guided natural killer cell therapies to treat patients with solid cancers.

NKIO

This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.

Nkarta

This biopharmaceutical company develops engineered natural killer cell therapies to treat patients with cancer and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Caribou Biosciences

This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.

Artiva

Artiva Biotherapeutics develops off-the-shelf natural killer cell therapies to treat patients with autoimmune diseases and cancers.